0001209191-23-059745.txt : 20231227 0001209191-23-059745.hdr.sgml : 20231227 20231226215629 ACCESSION NUMBER: 0001209191-23-059745 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231226 EFFECTIVENESS DATE: 20231227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spyre Therapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500772 FILM NUMBER: 231514494 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc. DATE OF NAME CHANGE: 20150311 D 1 primary_doc.xml X0708 D LIVE 0001636282 Spyre Therapeutics, Inc. 221 Crescent Street Building 23, Unit 105 Waltham MA MASSACHUSETTS 02453 617-651-5940 DELAWARE None Aeglea BioTherapeutics, Inc. Corporation true Cameron Turtle c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Executive Officer Director Scott Burrows c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Executive Officer Heidy King-Jones c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Executive Officer Jeffrey W. Albers c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Russell J. Cox c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Peter Harwin c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Michael Henderson c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Tomas Kiselak c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Alison Lawton c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Laurie Stelzer c/o Spyre Therapeutics, Inc. 221 Crescent Street,Building 23,Unit 105 Waltham MA MASSACHUSETTS 02453 Director Biotechnology Decline to Disclose 06b false 2023-12-11 false true false 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA true Cowen and Company, LLC 7616 None None 599 Lexington Avenue New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA true Stifel, Nicolaus & Company, Incorporated 793 None None 787 Seventh Avenue New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA true Guggenheim Securities, LLC 40638 None None 330 Madison Avenue New York NY NEW YORK 10017 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA true LifeSci Capital LLC 168404 None None 250 West 55th Street 34th Floor New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA true 180000000 180000000 0 false 30 0 10800000 0 false Spyre Therapeutics, Inc. /s/ Scott Burrows Scott Burrows Chief Financial Officer 2023-12-26